• No results found

[PDF] Top 20 Differential cytotoxic and radiosensitizing effects of silver nanoparticles on triple-negative breast cancer and non-triple-negative breast cells

Has 10000 "Differential cytotoxic and radiosensitizing effects of silver nanoparticles on triple-negative breast cancer and non-triple-negative breast cells" found on our website. Below are the top 20 most common "Differential cytotoxic and radiosensitizing effects of silver nanoparticles on triple-negative breast cancer and non-triple-negative breast cells".

Differential cytotoxic and radiosensitizing effects of silver nanoparticles on triple-negative breast cancer and non-triple-negative breast cells

Differential cytotoxic and radiosensitizing effects of silver nanoparticles on triple-negative breast cancer and non-triple-negative breast cells

... different breast cancer subtypes and nontumorigenic breast tissue has not been ...MDA-MB-231 cells, MCF-7 cells, and MCF-10A cells to AgNP exposure alone or combined with ... See full document

17

Comparative antiproliferative effects of iniparib and olaparib on a panel of triple negative and non triple negative breast cancer cell lines

Comparative antiproliferative effects of iniparib and olaparib on a panel of triple negative and non triple negative breast cancer cell lines

... combined effects of olaparib and neratinib as well as olaparib and afatinib on colony formation were investigated in four cell ...the effects of the dual treatment were cell ...JIMT1 cells, the ... See full document

9

CYTOTOXICITY AND IN SILICO STUDIES OF ANETHOLE IN TRIPLE NEGATIVE BREAST CANCER CELLS

CYTOTOXICITY AND IN SILICO STUDIES OF ANETHOLE IN TRIPLE NEGATIVE BREAST CANCER CELLS

... side effects, natural products are gaining more ...pro-cancerous effects depending on the estrogen receptor statuses in individual cell ...in breast cancer cells and to investigate the ... See full document

6

Anticancer efficiency of cycloartane triterpenoid derivatives isolated from <em>Cimicifuga yunnanensis</em> Hsiao on triple-negative breast cancer cells

Anticancer efficiency of cycloartane triterpenoid derivatives isolated from <em>Cimicifuga yunnanensis</em> Hsiao on triple-negative breast cancer cells

... against breast cancer cells: compound 4 (23-epi-26-deoxyactein) and compound 13 ...on triple-negative breast cancer (TNBC) cells in vivo and found that they could ... See full document

15

Silencing of CXCR4 sensitizes triple-negative breast cancer cells to cisplatin

Silencing of CXCR4 sensitizes triple-negative breast cancer cells to cisplatin

... Triple-negative breast cancer (TNBC) is an aggressive form of breast cancer for which there is no effective ...in breast cancer. In this study, we investigated the ... See full document

11

Real-world efficacy and safety of eribulin in advanced and pretreated HER2-negative breast cancer in a Spanish comprehensive cancer center

Real-world efficacy and safety of eribulin in advanced and pretreated HER2-negative breast cancer in a Spanish comprehensive cancer center

... An observational study was conducted at ICO-Hospitalet to review patients with HER2-negative ABC consecutively treated with single-agent eribulin from January 2014 to December 2017 in an off-trial setting. All ... See full document

7

Cyr61 as mediator of Src signaling in triple negative breast cancer cells

Cyr61 as mediator of Src signaling in triple negative breast cancer cells

... data. Differential expression of proteins between controls and Doxy-treated samples was determined by calculating weighted average ratios of peptides for each identified ... See full document

19

The BRG1 chromatin remodeling enzyme links cancer cell metabolism and proliferation

The BRG1 chromatin remodeling enzyme links cancer cell metabolism and proliferation

... for cancer therapy BRG1 function in cancer appears to be context ...primary breast and prostate tumors, in melanoma and neuroblastoma, and in pancreatic, gastric, and colorectal carcinomas [22, 23, ... See full document

12

Prognostic significance of c-Met in breast cancer: a meta-analysis of 6010 cases

Prognostic significance of c-Met in breast cancer: a meta-analysis of 6010 cases

... HRs with 95 % CIs were combined to determine the ef- fective value. If data on HRs and 95 % CIs were not pro- vided directly, the published data and Kaplan-Meier survival curves were used to calculate the HR according to ... See full document

10

Triple negative breast cancer: an Indian perspective

Triple negative breast cancer: an Indian perspective

... of breast cancer were prospectively enrolled in a longitudinal study at a tertiary care hospital in central India between 2012 and ...of breast lump by Vernier caliper and systemic investigations, ... See full document

5

CIP2A is a target of bortezomib in human triple negative breast cancer cells

CIP2A is a target of bortezomib in human triple negative breast cancer cells

... in cancer cell survival and apoptosis ...other breast tumor types [18]. Negative regulation of Akt signaling can be achieved by phosphatases, such as phosphatase and tensin homologue deleted on chro- ... See full document

14

Clinicopathological, therapeutic and prognostic features of the triple negative tumors in moroccan breast cancer patients (experience of Hassan II university hospital in Fez)

Clinicopathological, therapeutic and prognostic features of the triple negative tumors in moroccan breast cancer patients (experience of Hassan II university hospital in Fez)

... and triple negative (39%). Breast cancer patients with TNBC tumors had a poorer prognosis in terms of DFS and OS than those with luminal A tumors in the present study as pre- viously indicated ... See full document

6

Immunohistochemical Profile and Morphology in Triple – Negative Breast Cancers

Click here to download PDF version of the article !

... with triple-negative breast cancers have been shown to have a pathological complete response after the anthracycline + taxane based neoadjuvant chemotherapy ...of breast cancer, and the ... See full document

5

Novel therapeutic strategies for patients with triple-negative breast cancer

Novel therapeutic strategies for patients with triple-negative breast cancer

... TNBC cells in vitro due to G2/M cell cycle arrest and apoptosis, and decreased tumorigenesis in vivo and this was also an apparent partial reversal of epithelial-to-mesenchymal transition evidenced by increased ... See full document

10

A study of histomorphological profile of triple-negative breast cancer

A study of histomorphological profile of triple-negative breast cancer

... of cancer, which indicates the cell cycle disruption and imbalance between cell proliferation and cell ...of breast cancer and is considered the simplest tool to evaluate proliferation on H&E ... See full document

173

Immunotherapeutic interventions of Triple Negative Breast Cancer

Immunotherapeutic interventions of Triple Negative Breast Cancer

... TILs, cytotoxic T lymphocytes (CTLs), Th cells, NK and DC cells, large-scale ex vivo expansion and the activation of these lymphocytes for autologous therapy [109, ...tor cells, CTLs express a ... See full document

19

Osthole inhibits triple negative breast cancer cells by suppressing STAT3

Osthole inhibits triple negative breast cancer cells by suppressing STAT3

... noted that this suppression of signaling was seen in the com- bination treatment and it is not clear whether osthole along inhibits the pathway. Using a proteomic microarray contain- ing 19,394 proteins, we identified ... See full document

11

THE ROLE OF CHEMOTHERAPY IN TRIPLE NEGATIVE BREAST CANCER

THE ROLE OF CHEMOTHERAPY IN TRIPLE NEGATIVE BREAST CANCER

... Triple-negative breast cancers have a relapse pattern that is very different from hormone-positive breast cancers: the risk of relapse is much higher for the first 3–5 years but drops sharply ... See full document

5

Triple negative breast cancer: shedding light onto the role of pi3k/akt/mtor pathway

Triple negative breast cancer: shedding light onto the role of pi3k/akt/mtor pathway

... BC cells to anti-EGFR drugs (lapatinib) [88], demonstrating that this association may be responsible for an increased apoptosis in some TNBC cell lines and murine xenograft progression ... See full document

11

Systems biology analysis reveals NFAT5 as a novel biomarker and master regulator of inflammatory breast cancer

Systems biology analysis reveals NFAT5 as a novel biomarker and master regulator of inflammatory breast cancer

... Inflammatory breast cancer; Ki-67: Marker of proliferation Ki-67; aCGH: Array- comparative genomic hybridization; TGF β : Transforming growth factor beta 1; TF: Transcription factor; MR: Master regulator; ... See full document

13

Show all 10000 documents...